Impact of French Medicines Agency's communication on sodium valproate prescription in women of childbearing potential age - Université de Rennes Access content directly
Journal Articles Fundamental & Clinical Pharmacology Year : 2018
No file

Dates and versions

hal-01833091 , version 1 (09-07-2018)

Identifiers

  • HAL Id : hal-01833091 , version 1

Cite

A. Degremont, B. Le Nautout, C. Rault, E. Oger, A. Biraben, et al.. Impact of French Medicines Agency's communication on sodium valproate prescription in women of childbearing potential age. Fundamental & Clinical Pharmacology, 2018, 32, pp.6-6. ⟨hal-01833091⟩
53 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More